Cite

HARVARD Citation

    Viallard, J. et al. (2019). Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition?. Case reports in immunology. p. . [Online]. 
  
Back to record